← All trials

NCT04585815

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Nov 10, 2020
Primary completion
Oct 17, 2024
Completion date
Oct 17, 2024
First posted
Oct 14, 2020
Last posted
Dec 17, 2020
Enrollment
375
Arms / groups
1 / —
Source
AACT · ingestion pipeline

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.